ET covers C-CAMP startups Eyestem, Sekkei Bio and NBEC 2017 winner Chennai based FibSol

You are here

Economic Times has featured C-CAMP incubatees Eyestem Research working on retinal stem-cell therapy based cure for age-related macular degeneration and retinosis pigmentosa and Sekkei Bio, with a long-acting oral insulin drug and other therapeutic peptide drugs. C-CAMP BREC organised NBEC 2017 winner Chennai based startup FIB-SOL's nano-fibre biofertiliser agri solution has also been covered in the story.


May 29, 2018